These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26247263)

  • 21. Ketamine: A Cause of Urinary Tract Dysfunction.
    Myers FA; Bluth MH; Cheung WW
    Clin Lab Med; 2016 Dec; 36(4):721-744. PubMed ID: 27842789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced functional bladder capacity associated with ketamine use.
    Ramos SP; Zambonato TK; Graziottin TM
    Braz J Psychiatry; 2019; 41(3):270-271. PubMed ID: 31189007
    [No Abstract]   [Full Text] [Related]  

  • 23. Consider ketamine misuse in patients with urinary symptoms.
    Cottrell AM; Gillatt D
    Practitioner; 2008 Oct; 252(1711):5. PubMed ID: 18972794
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.
    Yek J; Sundaram P; Aydin H; Kuo T; Ng LG
    Singapore Med J; 2015 Dec; 56(12):660-4; quiz 665. PubMed ID: 26702160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine-induced vesicopathy: a literature review.
    Middela S; Pearce I
    Int J Clin Pract; 2011 Jan; 65(1):27-30. PubMed ID: 21155941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ureteric intestinal metaplasia in association with chronic recreational ketamine abuse.
    Hopcroft SA; Cottrell AM; Mason K; Abrams P; Oxley JD
    J Clin Pathol; 2011 Jun; 64(6):551-2. PubMed ID: 21345876
    [No Abstract]   [Full Text] [Related]  

  • 27. Patterns of polydrug use among ketamine injectors in New York City.
    Lankenau SE; Clatts MC
    Subst Use Misuse; 2005; 40(9-10):1381-97. PubMed ID: 16048823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. British Association of Urological Surgeons Consensus statements on the management of ketamine uropathy.
    Belal M; Downey A; Doherty R; Ali A; Hashim H; Kozan A; Kujawa M; Pakzad M; Rashid T; Osman N; Sahai A; Biers S;
    BJU Int; 2024 Aug; 134(2):148-154. PubMed ID: 38778743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pattern and prevalence of upper gastrointestinal toxicity in patients abusing ketamine.
    Liu SYW; Ng SKK; Tam YH; Yee SCH; Lai FPT; Hong CYL; Chiu PWY; Ng EKW; Ng CF
    J Dig Dis; 2017 Sep; 18(9):504-510. PubMed ID: 28749602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Illegal use patterns, side effects, and analytical methods of ketamine.
    Han E; Kwon NJ; Feng LY; Li JH; Chung H
    Forensic Sci Int; 2016 Nov; 268():25-34. PubMed ID: 27685472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nerve hyperplasia: a unique feature of ketamine cystitis.
    Baker SC; Stahlschmidt J; Oxley J; Hinley J; Eardley I; Marsh F; Gillatt D; Fulford S; Southgate J
    Acta Neuropathol Commun; 2013 Oct; 1():64. PubMed ID: 24252413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an addiction index and delineation 15-year trends of illicit drugs from the Taiwan national drug enhancement database.
    Lin C; Wong BY; Lo MT; Chiu YC; Lin YH
    J Psychiatr Res; 2020 Jan; 120():131-136. PubMed ID: 31670261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.
    Lai Y; Wu S; Ni L; Chen Z; Li X; Yang S; Gui Y; Guan Z; Cai Z; Ye J
    Urol Int; 2012; 89(1):93-6. PubMed ID: 22710265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis.
    Turkish A; Luo JJ; Lefkowitch JH
    Hepatology; 2013 Aug; 58(2):825-7. PubMed ID: 23695896
    [No Abstract]   [Full Text] [Related]  

  • 35. [Imaging features of urinary dysfunction associated with ketamine abuse].
    Wu P; Zhao J; Gao L; Wang Y; Zheng H; Huang Z; Gu D; Huang J; Zheng S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1143-7. PubMed ID: 22931608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of ketamine dependence].
    Błachut M; Sołowiów K; Janus A; Ruman J; Cekus A; Matysiakiewicz J; Hese RT
    Psychiatr Pol; 2009; 43(5):593-9. PubMed ID: 20214100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketamine use: a review.
    Morgan CJ; Curran HV;
    Addiction; 2012 Jan; 107(1):27-38. PubMed ID: 21777321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketamine cystitis: practical considerations in management.
    Misra S; Chetwood A; Coker C; Thomas P
    Scand J Urol; 2014 Oct; 48(5):482-8. PubMed ID: 24779452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based survey of the prevalence of lower urinary tract symptoms in adolescents with and without psychotropic substance abuse.
    Tam YH; Ng CF; Wong YS; Pang KK; Hong YL; Lee WM; Lai PT
    Hong Kong Med J; 2016 Oct; 22(5):454-63. PubMed ID: 27516568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Chinese version of the pelvic pain and urgency/frequency symptom scale: a useful assessment tool for street-ketamine abusers with lower urinary tract symptoms.
    Ng CM; Ma WK; To KC; Yiu MK
    Hong Kong Med J; 2012 Apr; 18(2):123-30. PubMed ID: 22477735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.